261 related articles for article (PubMed ID: 23817395)
21. The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin.
Byrne B; O'Shea P; Barrett P; Tormey W
Clin Chem Lab Med; 2010 Feb; 48(2):205-8. PubMed ID: 19943807
[TBL] [Abstract][Full Text] [Related]
22. Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients.
Kavanagh-Wright L; Smith TP; Gibney J; McKenna TJ
Clin Endocrinol (Oxf); 2009 Apr; 70(4):599-605. PubMed ID: 18771565
[TBL] [Abstract][Full Text] [Related]
23. Roche Elecsys Prolactin II assay: reactivity with macroprolactin compared with eight commercial assays for prolactin and determination of monomeric prolactin by precipitation with polyethylene glycol.
Fahie-Wilson M; Bieglmayer C; Kratzsch J; Nusbaumer C; Roth HJ; Zaninotto M; Plebani M; Hubbuch A; Schneider E
Clin Lab; 2007; 53(5-6):301-7. PubMed ID: 17605405
[TBL] [Abstract][Full Text] [Related]
24. Serum total prolactin and monomeric prolactin reference intervals determined by precipitation with polyethylene glycol: evaluation and validation on common immunoassay platforms.
Beltran L; Fahie-Wilson MN; McKenna TJ; Kavanagh L; Smith TP
Clin Chem; 2008 Oct; 54(10):1673-81. PubMed ID: 18719199
[TBL] [Abstract][Full Text] [Related]
25. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
[TBL] [Abstract][Full Text] [Related]
26. Reference ranges for serum total and monomeric prolactin for the current generation Abbott Architect assay.
Whitehead SJ; Cornes MP; Ford C; Gama R
Ann Clin Biochem; 2015 Jan; 52(Pt 1):61-6. PubMed ID: 25074991
[TBL] [Abstract][Full Text] [Related]
27. [Usefulness of Polyethylene-Glycol Precipitation As a Screening Method for Macroprolactinemia].
Yamakami A; Takahashi R; Fukazawa C; Tanaka C; Takeda K
Rinsho Byori; 2016 Sep; 64(9):1012-1015. PubMed ID: 30609453
[TBL] [Abstract][Full Text] [Related]
28. The detection of macroprolactin by precipitation and ultrafiltration methods.
Beda-Maluga K; Pisarek H; Komorowski J; Pawlikowski M; Świętosławski J; Winczyk K
Endokrynol Pol; 2011; 62(6):529-36. PubMed ID: 22144220
[TBL] [Abstract][Full Text] [Related]
29. Free prolactin determinations in hyperprolactinemic men with suspicion of macroprolactinemia.
Sapin R; Gasser F; Grucker D
Clin Chim Acta; 2002 Feb; 316(1-2):33-41. PubMed ID: 11750272
[TBL] [Abstract][Full Text] [Related]
30. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition.
Olukoga AO; Kane JW
Clin Endocrinol (Oxf); 1999 Jul; 51(1):119-26. PubMed ID: 10468974
[TBL] [Abstract][Full Text] [Related]
31. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
Shimatsu A; Hattori N
Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
[TBL] [Abstract][Full Text] [Related]
32. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
Hu Y; Ni J; Zhang B; Cheng W; Zhang H; Ye H; Ji L; Lu B; Guan M
BMC Endocr Disord; 2021 Oct; 21(1):197. PubMed ID: 34620143
[TBL] [Abstract][Full Text] [Related]
33. Macroprolactinemia Detection by Magnetically Assisted Polyethylene Glycol Precipitation: Potential for Automation.
Smith T; Stern E; Tan E; Vacic A; Fahie-Wilson M
J Appl Lab Med; 2020 May; 5(3):494-505. PubMed ID: 32445359
[TBL] [Abstract][Full Text] [Related]
34. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol.
Fahie-Wilson MN; Soule SG
Ann Clin Biochem; 1997 May; 34 ( Pt 3)():252-8. PubMed ID: 9158821
[TBL] [Abstract][Full Text] [Related]
35. Patients with macroprolactinaemia: clinical and radiological features.
Donadio F; Barbieri A; Angioni R; Mantovani G; Beck-Peccoz P; Spada A; Lania AG
Eur J Clin Invest; 2007 Jul; 37(7):552-7. PubMed ID: 17576206
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of macroprolactin detected by Elecsys 2010.
Sánchez-Eixerés MR; Mauri M; Alfayate R; Graells ML; Miralles C; López A; Picó A
Horm Res; 2001; 56(3-4):87-92. PubMed ID: 11847468
[TBL] [Abstract][Full Text] [Related]
37. Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.
McCudden CR; Sharpless JL; Grenache DG
Clin Chim Acta; 2010 Feb; 411(3-4):155-60. PubMed ID: 19895797
[TBL] [Abstract][Full Text] [Related]
38. A practical method for the detection of macroprolactinaemia using ultrafiltration.
Prazeres S; Santos MA; Ferreira HG; Sobrinho LG
Clin Endocrinol (Oxf); 2003 Jun; 58(6):686-90. PubMed ID: 12780743
[TBL] [Abstract][Full Text] [Related]
39. Clinical characterization of patients with macroprolactinemia and monomeric hyperprolactinemia.
Can M; Guven B; Atmaca H; Acıkgoz S; Mungan G
Kaohsiung J Med Sci; 2011 May; 27(5):173-6. PubMed ID: 21527183
[TBL] [Abstract][Full Text] [Related]
40. Macroprolactin: what is it and what is its importance?
Sadideen H; Swaminathan R
Int J Clin Pract; 2006 Apr; 60(4):457-61. PubMed ID: 16620360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
